The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
The PI3K/AKT/mTOR interactive pathway
Open accessAbstract
The phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of the rapamycin (mTOR) signalling pathway is hyperactivated or altered in many cancer types and regulates a broad range of cellular processes including survival, proliferation, growth, metabolism, angiogenesis and metastasis. The PI3K/AKT/mTOR pathway is regulated by a wide-range of upstream signalling proteins and it regulates many downstream effectors by collaborating with various compensatory signalling pathways, primarily with RAF/MEK/ERK pathway. Limited clinical success of the available targeted therapeutic agents and challenges mediated by tumour heterogeneity across different cancer types emphasize the importance of alterations in the PI3K/AKT/mTOR pathway in the design of effective personalized treatment strategies. Here we report a comprehensive PI3K/AKT/mTOR network that represents the intricate crosstalk between compensatory pathways, which can be utilized to study the AKT signalling mechanism in detail and improve the personalized combinatorial therapeutic strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PI3K inhibition, shown to increase autophagy38.”
From APOE4/4 is linked to damaging lipid droplets in Alzheimer’s disease microglia (2024) · cites this paper as [38]
Citations
Cites
1 retracted
Yuan, Z., Feldman, R. I., Sun, M., Olashaw, N., Coppola, D., Sussman, G. E., Shelley, S. A., Nicosia, S. V., & Cheng, J. Q. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203636200 · Cited by 52
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Flagged first, then by citations
1 of the 125 references couldn’t be matched to a known paper.
Research works printed but not linked: 8
- Guan, 2000, J. Biol. Chem., 275, 27354, 10.1016/S0021-9258(19)61518-8 · DOI
- Chung, 2012, J. Cell Sci., 125, 2684
- Lamouille, 2014, Nat. Rev. Mol. Cell Biol., 15, 178, 10.1038/nrm3758 · DOI · Paper page
- Su, 2003, Cancer Res., 63, 3585
- Zhou, 2003, Cancer Res., 63, 6357
- Xu, 2002, Cancer Res., 62, 4588
- Gatei, 2000, Cancer Res., 60, 3299
- Carracedo, 2008, J. Clin. Invest., 118, 3065
Cited by
Sorted by citations
Items 501–600 of 684
de Almeida, I. M., Tosta, B. R., Pena, L. D. C., Silva, H. D. S., Góes, F. D. S. R., Silva, N. N., Cruz, J. V. A., Silva, M. D. A., de Araújo, J. F., Rodrigues, J. L., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1422349 · Cited by 2
Markelov, V. A., Korytina, G. F., Aznabaeva, Y. G., Асхатович, Г. И., Akhmadishina, L. Z., Насибуллин, Т. Р., Kochetova, O. V., Avzaletdinov, A. M., & Zagidullin, N. S. (2024) · Molecular Biology · doi:10.1134/s0026893324700481 · Cited by 2
10-Methoxy-leonurine accelerated wound healing through ErbB4/PI3K-AKT pathway
Zhang, Y., Tan, B.-Y., Peng, H., Duan, Y., Wen, X., Li, X., Wu, X.-R., Zhao, Y., & Luo, X. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119641 · Cited by 2
Stokes, A. E., Clark, H. M., Edwards, J. L., Payton, R. R., Beever, J. E., Freeman, T. F., Hessock, E. A., Schrick, F. N., & Moorey, S. E. (2025) · BMC Genomics · doi:10.1186/s12864-025-11521-0 · Cited by 2
Strength training and sarcopenia—a mandatory link: focus on MicroRNAs
Cione, E., Abrego-Guandique, D. M., Chiari, A., & Cannataro, R. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1554340 · Cited by 2
Li, Y., Xu, Q., Chen, Z., Chen, M., Han, K., Zhang, Z., Shen, A., & Fu, X. (2025) · Digestive Diseases · doi:10.1159/000547374 · Cited by 2
Nie, M., Li, X., Xiao, Y., Lei, S., & Wu, D. (2025) · The FASEB Journal · doi:10.1096/fj.202502341r · Cited by 2
Lu, S., Yue, B., Tang, Y., Xu, H., Xu, R., Zhao, X., Wei, Q., Xue, J., Pan, M., Peng, S., et al. (2025) · Theriogenology · doi:10.1016/j.theriogenology.2025.117666 · Cited by 2
Xu, X., Dai, X., Zhao, Y., Sun, Y., Shi, L., & Qi, Y. (2025) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2025.100134 · Cited by 2
Zani, A., Bugatti, A., Maceroni, E., Duheric, M., Uggeri, M., Manocha, E., Bertelli, M., d’Angelo, M., Cimini, A., Caccuri, F., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.108042 · Cited by 2
Fraxin modulates lipid metabolism as well as gut flora to avert NAFLD
Jing, Y., Huicong, D., Xuanchi, G., Cao, L., Huanhuan, Z., & Yongze, G. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1657966 · Cited by 2
Genes and Genetic Pathways Regarding the Etiology and Pathogenesis of Ameloblastoma
Zisis, V., Papadopoulos, P., Papadopoulos, S., Poulopoulos, K., Charisi, C., Parlitsis, D., & Poulopoulos, A. K. (2026) · Genes · doi:10.3390/genes17010065 · Cited by 2
Niculae, D. A., Serban, R. M., Niculae, D., & Drăgănescu, D. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18010131 · Cited by 3
Liu, R., Zhi, L., Liang, Y., Jiang, H., Xin, W., Yan, N., & Li, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1806321 · Cited by 3
Li, W., Wang, S., Wang, Z., Fan, H., & You, H. (2026) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2026.117833 · Cited by 2
Chu, H., & Wang, D. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1796656 · Cited by 2
Günay, Ç., Kurul, S. H., & Yiş, U. (2023) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_92_23 · Cited by 2
ABCA4 mediated traumatic proliferative vitreoretinopathy associated with PI3K/Akt signaling pathway
Menghua, W., & Hu, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27024 · Cited by 2
Influence of SphK1 on Inflammatory Responses in Lipopolysaccharide-Challenged RAW 264.7 Cells
Wei, C.-S., Song, L.-L., Peng, Z.-X., & Wang, X.-L. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01364-z · Cited by 2
Zhou, H., Xu, Y., Cui, A., Jiang, Y., Feng, Y., Ma, B., & Wang, B. (2024) · Aquaculture Reports · doi:10.1016/j.aqrep.2024.102221 · Cited by 2
mTORC1 and mTORC2 Levels in Patients With Psoriasis
Gülsunay, İ. E., Altunay, İ. K., Kum, T., & Çerman, A. A. (2024) · Dermatology Practical & Conceptual · doi:10.5826/dpc.1404a266 · Cited by 2
Wang, Q., Zhu, Y. J., Zhang, Y. L., Chen, C., Fan, J., Yin, A., Guo, S., & Liu, Y. (2026) · Discover Oncology · doi:10.1007/s12672-026-05302-8 · Cited by 2
Xing, J., Feng, X., Zhang, R., & Zhang, K. (2025) · Cancers · doi:10.3390/cancers17030443 · Cited by 2
Megid, R., Ribeiro, G., Gomes, I. N. F., Laus, A. C., Leal, L. F., da Silva, L. S., Ariwoola, A.-B. A., Dias, J. M., Reis, R. M., & Oliveira, R. J. D. S. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1537523 · Cited by 3
Zhu, X., Miao, L., Li, J., Wang, X., Li, L., Zhang, Y., Sun, M., Meng, S., Ren, J., Peng, Q., et al. (2025) · Fitoterapia · doi:10.1016/j.fitote.2025.106486 · Cited by 2
Therapeutic mechanism of nano-selenium in hexavalent chromium poisoning in laying hens
Zhou, C., Zhao, X., & Zhou, D. (2025) · Animal Diseases · doi:10.1186/s44149-025-00169-8 · Cited by 2
Targeting Leader Cells in Ovarian Cancer as an Effective Therapeutic Option
Karimnia, N., Ho, G., Stephens, A. N., & Bilandzic, M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98689 · Cited by 2
Glioblastoma a Malignant Form of Tumor: a Review on Its Cellular Target, Route, and Its Treatment
Amin, I., & Saxena, P. (2022) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-022-00037-4 · Cited by 2
Rojas-Rodríguez, F., Morantes, C., Pinzón, A. M., Barreto, G. E., Cabezas, R., Mariño‐Ramírez, L., & González, J. (2020) · The Open Bioinformatics Journal · doi:10.2174/1875036202013010001 · Cited by 2
Effect of Acidosis-Induced Signalling Pathways on Mitochondrial O2 Consumption of Tumour Cells
Degitz, C., Reime, S., & Thews, O. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-14190-4_38 · Cited by 2
Al-Bustany, H. A., Muhammad, H. A., Chawsheen, M. A., & Dash, P. R. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110885 · Cited by 2
Cai, H., Zheng, R., Wu, N., Hu, J., Wang, R., Chi, J., Zhang, W., Zhao, L., Cheng, H. B., Chen, A., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102377 · Cited by 2
CRH upregulates supervillin through ERK and AKT pathways to promote bladder cancer cell migration
Mao, R., Zhou, F., Hong, Y., Li, Y., Zhu, C., Jin, L., & Li, S. (2024) · Cell Biology International · doi:10.1002/cbin.12227 · Cited by 2
Li, M., Ran, Q., Du, X., Chen, K., Yang, Q., Zhu, X., & Li, Q. (2023) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2023.3591 · Cited by 1
Liang, Y. Y., Liao, X. Y., Jia, J. J., Yin, Y. Z., Zhang, Y. H., & GAO, F. G. (2024) · Immunology · doi:10.1111/imm.13787 · Cited by 1
Bhavitha, N. (2024) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2024.63353 · Cited by 1
Amadeo, E., Foti, S., Camera, S., Rossari, F., Persano, M., Prinzi, F. L., Vitiello, F., Gardini, A. C., & Rimini, M. (2024) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2024.2377321 · Cited by 1
Xu, J., Zhang, C., Wang, L., Wang, M., Liang, J., Yang, Y., & Zhang, X. (2024) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073303380240722112207 · Cited by 1
Exploring miRNA profile associated with cisplatin resistance in ovarian cancer cells
Alghamian, Y., Soukkarieh, C., Aljapawe, A., & Murad, H. (2024) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2024.101906 · Cited by 1
Cui, H. S., Zheng, Y., Cho, Y. S., Ro, Y. M., Kwak, I. S., Joo, S. Y., & Seo, C. H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125876 · Cited by 2
闫, 舒. (2025) · Traditional Chinese Medicine · doi:10.12677/tcm.2025.148517 · Cited by 1
He, Z., Chen, J., Wu, H. M., Shen, H., & Li, R. (2025) · International Archives of Allergy and Immunology · doi:10.1159/000547368 · Cited by 1
Sun, S., Fan, R., Siddiqui, J. A., Ma, W., Chen, X., & Smagghe, G. J. (2025) · Archives of Insect Biochemistry and Physiology · doi:10.1002/arch.70106 · Cited by 1
Oncogenesis in cholangiocarcinoma
Orzan, R. I., & Seicean, A. (2025) · Advances in clinical chemistry · doi:10.1016/bs.acc.2025.10.008 · Cited by 1
Shi, M., Chen, L., Xu, J., Zhang, J., Yang, C., Wang, Q., Yang, J., Xu, F., Shi, J., & Qin, Y. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112247 · Cited by 1
Contribution of omics to the pathophysiology of diaphragmatic hernias: a narrative review
Leyne, E., Bouligand, J., Wagner, R., Abgral, M., Benachi, A., & Vivanti, A. J. (2025) · European Journal of Pediatrics · doi:10.1007/s00431-025-06653-0 · Cited by 1
Chen, Y., Li, X., Chen, A., Liao, Z., Gu, X., Chen, X., Tao, Y., Zhang, W., He, X. Z., Li, W., et al. (2025) · Animal nutrition · doi:10.1016/j.aninu.2025.07.007 · Cited by 3
Yan, Z., Chen, X., Cao, X., Fan, J., Duan, L., Wu, N., Xin, J., Li, X., Xu, X., & Zhang, H. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s555252 · Cited by 1
Wang, S. N., Tang, F. N., Chen, H. N., Pang, J., Zhang, Y. N., Yang, J., & Zhang, Y. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl46765 · Cited by 1
Rodriguez, V., Villani, A., Sénica, M., Panebianco, C., Pazienza, V., & Preto, A. (2026) · Cancers · doi:10.3390/cancers18030369 · Cited by 1
Ni, Q., Ying, D., Chang, J., Yu, H., & Li, X. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04239-w · Cited by 1
Regulatory roles of microRNAs in signaling pathways and their biomarker potential in prostate cancer
Kalarestaghi, H., Amani, N., & Shoorei, H. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04236-z · Cited by 1
Kushawaha, S. K., Vashisht, K., Kumar, H., Ankalgi, A. D., Ashawat, M. S., & Baldi, A. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02215-4 · Cited by 1
Zhou, L., Fei, C., & Liu, Q. (2026) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2026.1796216 · Cited by 1
Research Progress on the Role of the PI3K/AKT Signaling Pathway in Osteoarthritis
袁, 景. (2026) · Traditional Chinese Medicine · doi:10.12677/tcm.2026.155250 · Cited by 1
Chen, J., Zhao, J., Zhang, X., & Zhu, H. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1768252 · Cited by 1
Kim, H., Lee, Y. J., Park, S.-J., Choi, H., Yang, J. S., Kim, K. S., & Jun, W. (2026) · Marine Drugs · doi:10.3390/md24070233 · Cited by 1
Milano, F., Clemente, F., Cardona, F., Goti, A., Quarta, A., Marradi, M., Ragusa, A., & Matassini, C. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119254 · Cited by 1
Lactylation of GDF15 Regulates Angiogenesis in Ischemic Stroke via Activating PI3K/AKT/mTOR Pathway
Yu, X., Chen, G., Zou, W., Deng, Y., Hu, M., He, X., Chen, H., & Liu, C. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06118-x · Cited by 1
Xing, X., Liu, H., Pang, Y., & Li, S. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108850 · Cited by 1
Rigotto, G., Montini, B., Mattiolo, A., Lazzari, N., Piano, M. A., Remondini, D., Marmiroli, S., Bertacchini, J., Chieco‐Bianchi, L., & Calabrò, M. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910562 · Cited by 1
ÇELİK, İ. S., Aygan, A., Çiçek, M., & Kocabaş, Y. Z. (2022) · Sakarya University Journal of Science · doi:10.16984/saufenbilder.1221057 · Cited by 1
Markelov, V. A., Korytina, G. F., Aznabaeva, Y. G., Рустэмович, З. Ш., Akhmadishina, L. Z., & Zagidullin, N. S. (2023) · Genes and Cells · doi:10.23868/gc248366 · Cited by 1
Lee, S. U., & Kim, Y. H. (2023) · Natural Product Communications · doi:10.1177/1934578x231194420 · Cited by 1
Zhou, J., Qiao, C., Gao, Y., Wang, H., Li, J., Yang, S., Chai, K., Zhao, T. T., & Wu, J. (2024) · Medicine · doi:10.1097/md.0000000000037674 · Cited by 1
Recent Insights into the Roles of PEST‐Containing Nuclear Protein
Guo, S., Ding, R., Zhao, Q., Wang, X., Lv, S., & Ji, X. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01188-5 · Cited by 1
Chen, Y., Zhou, Y., Chen, J.-L., Luo, Y.-P., Feng, C.-Z., & Fan, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37249 · Cited by 1
Luo, Y., Wang, Z., Li, Y., & Zhang, L. (2024) · Journal of Cancer · doi:10.7150/jca.102125 · Cited by 1
Association of Somatic KRAS Variants with Osteolysis in Arteriovenous Malformations
Basilio, M. S., Rodríguez‐Laguna, L., Triana, P., Martínez‐Glez, V., Ramírez‐Amorós, C., Delgado‐Miguel, C., Arias, J. P. R., & López‐Gutiérrez, J. C. (2025) · European Journal of Pediatric Surgery · doi:10.1055/a-2540-3621 · Cited by 1
The Regulatory Effects of Pea Protein Hydrolysate on Lipid Metabolism in Gestational Diabetic Mice
Yu, T., Shang, N., Chen, L., Lü, K., Xia, H., Yang, L., Wang, S., Sun, G., & Liao, W. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70178 · Cited by 2
Tmprss6 modulates radiation-induced liver injury through the hepcidin axis and PI3K/AKT pathway
Zhou, Y., Wang, Z., Gao, J.-Q., Xu, J., Qin, L. Y., He, Y., Li, M., & He, J. (2025) · International Journal of Radiation Biology · doi:10.1080/09553002.2025.2527894 · Cited by 1
Oncogenetics of Lung Cancer Induced by Environmental Carcinogens
Martínez, V. D., Sage, A. P., Marshall, E. A., Suzuki, M., Goodarzi, A. A., Dellaire, G., & Lam, W. L. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81064 · Cited by 1
PTP-PEST: Vías de señalización y su importancia como blanco terapéutico en cáncer
Manzanita-Quintero, K., Lee-Rivera, I., López, E., & López-Colomé, A. M. (2022) · TIP Revista Especializada en Ciencias Químico-Biológicas · doi:10.22201/fesz.23958723e.2022.503 · Cited by 1
Rojas-Rodríguez, F., Morantes, C., Pinzón, A. M., Barreto, G. E., Cabezas, R., Mariño‐Ramírez, L., & González, J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/740050 · Cited by 1
Qadri, O., Bashir, S., Banday, M., Pal, D., & Fazili, K. M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.09.451832 · Cited by 1
Withdrawn: POI Culprit Is POSSIBLY Gene Mutation: A Literature ReviewPreprint
Miao, C., Fang, Q., Kang, Q., & He, J. (2024) · Preprints.org · doi:10.20944/preprints202406.0046.v1 · Cited by 1
Cirnu, A., Williams, T., Noerpel, M., Kammerer, J., Kannt, S., Heil, M., Kimmel, L., Arias-Loza, P.-A., Lhoda, M., Hennig, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.11.693827 · Cited by 1
Burn-Induced Muscle Wasting: Changes in Muscle Progenitor Cells
Yousuf, Y. (2018) · TSpace (University of Toronto)
Diaconu, B. (2019) · UWSpace (University of Waterloo)
LincRNA-p21 reverses irinotecan resistance in colon cancer cells via the PI3K/AKT signaling pathway
Dai, D.-P., Yu, L.-Z., & Ye, M.-F. (2019) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v27.i22.1356
Molecular-Genetic Features of Pancreatic Neuroendocrine Tumors
Kit, O. I., Gvaldin, D. Y., Trifanov, V. S., Kolesnikov, E. N., & Тимошкина, Н. Н. (2020) · Russian Journal of Genetics · doi:10.1134/s1022795420020064
Jayanti, D. A. P. I. S., Abimanyu, I. G. A., & Azzamudin, H. (2021) · JSMARTech · doi:10.21776/ub.jsmartech.2021.002.03.87
Zhang, Z., Su, Z., & Zhang, J. (2022) · Research Square · doi:10.21203/rs.3.rs-966855/v1
Zhu, W. L., Ying, J. Y., & Qin, H. X. (2022) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.spl.485
May, A. J., Mattingly, A. J., Gaylord, E. A., Cruz‐Pacheco, N., Emmerson, E., Sudiwala, S., Mohabbat, S., Nathan, S., Sinada, H., Lombaert, I. M. A., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4090930
Franco‐García, A., Guerrero-Bautista, R., Hidalgo, J. M., Milanés, M. V., Gómez‐Murcia, V., & Núñez, C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.12.507553
Hao, Y., Zhang, F., Ma, Y., Luo, Y., Zhang, Y., Yang, N., Liu, M., Luo, M., Teng, J., & Li, J. (2022) · doi:10.2196/preprints.43865
Hao, Y., Ji, J., Liu, C., Zhang, N., & Gong, Y. (2022) · PubMed Central · doi:10.12122/j.issn.1673-4254.2022.11.20
Qiu, W., Ren, M., Wang, C., Fu, Y., & Liu, Y. (2022) · Medicine · doi:10.1097/md.0000000000032340 · Cited by 1
Data from Midkine Promotes Metastasis and Therapeutic Resistance via mTOR/RPS6 in Uveal Melanoma
Karg, M. M., John, L., Refaian, N., Buettner, C., Rottmar, T., Sommer, J., Bock, B., Resheq, Y. J., Ksander, B. R., Heindl, L. M., et al. (2023) · doi:10.1158/1541-7786.c.6545630.v1
Data from Midkine Promotes Metastasis and Therapeutic Resistance via mTOR/RPS6 in Uveal Melanoma
Karg, M. M., John, L., Refaian, N., Buettner, C., Rottmar, T., Sommer, J., Bock, B., Resheq, Y. J., Ksander, B. R., Heindl, L. M., et al. (2023) · doi:10.1158/1541-7786.c.6545630
Xu, L., Li, S., Zhao, R., Sun, W., & Li, H. (2023) · Research Square · doi:10.21203/rs.3.rs-2822563/v1
Fung, J., Ostoich, K. C., Stephanovic, M., Pataguana, N., & Winters, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821617-0.00003-6
Bai, M., Jiang, N., Fu, W., Huang, C., Tian, L., Mi, N., Gao, L., Ma, H., Lu, Y., Cao, J., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3167220/v1
She, Y., Yang, J., Zhu, M., Liu, Z., Liu, B., Ma, X., Wang, L., & Li, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-3194487/v1
Shang, L., Li, X., Ding, X., Liu, G., Pan, Z., Chen, X., Wang, Y., Li, B., Wang, T., & Zhao, C. (2023) · Research Square · doi:10.21203/rs.3.rs-3187175/v1
Metadata
- Authors
- Ersahin, T., Tuncbag, N., & Cetin-Atalay, R.
- Affiliations
- Cancer Systems Biology Laboratory, Graduate School of Informatics, ODTU a , 06800 Ankara, Turkey rengul@metu.edu.tr +90-312-210-3745 +90-312-210-7887
- Venue
- Molecular BioSystems
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-20
- Volume
- 11
- Issue
- 7
- Pages
- 1946-1954
- ISSN
- 1742-2051 (ISSN-L)
- 1742-206X
- OpenAlex
- W2062689336
- Cited by
- 683
- References
- 125
- Citations by year
- 2026: 62 · 2025: 110 · 2024: 119 · 2023: 96 · 2022: 82 · 2021: 71 · 2020: 56 · 2019: 43 · 2018: 30 · 2017: 8 · 2016: 5 · 2015: 1
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- Molecular BioSystems (publishedVersion)
- PubMed (publishedVersion)
- OpenMETU (Middle East Technical University) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- PI3K/AKT/mTOR pathway, Raf/MEK/ERK pathway, pathway crosstalk, cancer, tumor heterogeneity, precision oncology, combination therapy, targeted therapy resistance
- MeSH terms
- Humans, Phosphatidylinositol 3-Kinases, MAP Kinase Signaling System, Proto-Oncogene Proteins c-akt, TOR Serine-Threonine Kinases, Protein Interaction Maps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review